Xenograft studies demonstrated two-fold increase in tumor growth when the human MDA-MB-231 breast cancer cells were co-injected alongside BRCA1 knocked-down fibroblasts into nude mice, thus, demonstrating the potential effects of BRCA1-deficient tumor stroma on breast cancer growth and invasion [77]. This evidence concerns the gene BRCA1 and breast carcinoma.